Adjuvatis
Pre-clinicali-Particles® technology originates from the fundamental statement that pharmaceuticals should never involve harmful by-products and only focus on patient safety. Starting from this idea, Adjuvatis technology is led by one main concept: safe-by-design.
Founded
2016
Focus
VaccinesImmunology
About
i-Particles® technology originates from the fundamental statement that pharmaceuticals should never involve harmful by-products and only focus on patient safety. Starting from this idea, Adjuvatis technology is led by one main concept: safe-by-design.
Funding History
3Total raised: $6M
Series AUndisclosedUndisclosedJun 15, 2023
Seed$3.5MUndisclosedJun 15, 2021
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2016
LocationLyon, France
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adocia
Phase 3 · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile